INT166177

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.48
First Reported 2008
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 5
Total Number 8
Disease Relevance 4.64
Pain Relevance 0.26

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (H1fnt) chromosome (H1fnt) nucleus (H1fnt)
DNA binding (H1fnt)
Anatomy Link Frequency
respiratory 1
H1fnt (Mus musculus)
Pain Link Frequency Relevance Heat
headache 16 91.28 High High
Analgesic 16 45.32 Quite Low
Pain 1 25.00 Low Low
cytokine 8 5.00 Very Low Very Low Very Low
depression 8 5.00 Very Low Very Low Very Low
anesthesia 3 5.00 Very Low Very Low Very Low
addiction 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Influenza Virus Infection 248 100.00 Very High Very High Very High
Sprains And Strains 124 100.00 Very High Very High Very High
Infection 94 100.00 Very High Very High Very High
Pox Virus Infection 52 100.00 Very High Very High Very High
Respiratory Syncytial Virus 50 99.80 Very High Very High Very High
Lower Respiratory Tract Infection 4 96.36 Very High Very High Very High
Headache 16 91.28 High High
Immunization 22 79.88 Quite High
Pneumonia 5 70.08 Quite High
Syndrome 8 61.40 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
If a significant number of cases appear in older persons, the recommendations for H1N1 vaccination may need to be changed to include the elderly.
Gene_expression (vaccination) of H1N1
1) Confidence 0.48 Published 2010 Journal J Am Med Dir Assoc Section Abstract Doc Link 20129209 Disease Relevance 0.17 Pain Relevance 0
For children, the rate differences for all solicited symptoms were not statistically significant between H1N1 LAIV and placebo recipients.
Neg (not) Gene_expression (significant) of H1N1 LAIV
2) Confidence 0.31 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2966412 Disease Relevance 0.31 Pain Relevance 0.26
The seroresponse rates observed in placebo recipients in both studies is likely attributable to 2009 H1N1 infections occurring in the U.S. during the period in which these studies were conducted.
Gene_expression (infections) of H1N1 associated with infection
3) Confidence 0.27 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2966412 Disease Relevance 0.43 Pain Relevance 0
In response to the 2009 H1N1 influenza pandemic, MedImmune (Gaithersburg, MD) developed a live attenuated intranasal H1N1 vaccine based on the Ann Arbor 6?
Gene_expression (vaccine) of H1N1 associated with influenza virus infection
4) Confidence 0.27 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2966412 Disease Relevance 0.36 Pain Relevance 0
The 2009 H1N1 LAIV was produced by MedImmune and was derived by genetic reassortment of the hemagglutinin and neuraminidase genes from the wild-type A/California/7/2009 virus and the remaining 6 gene segments from an attenuated master donor virus as previously described [1], [2], [18].
Gene_expression (produced) of H1N1 LAIV
5) Confidence 0.24 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2966412 Disease Relevance 0.10 Pain Relevance 0
The purpose of this study was to evaluate the immune response and the protective potential of MVA-based influenza vaccines expressing the protective antigens hemagglutinin and neuraminidase of the novel H1N1 strain.
Gene_expression (expressing) of H1N1 associated with influenza virus infection and sprains and strains
6) Confidence 0.01 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2922371 Disease Relevance 0.41 Pain Relevance 0
In the current study, experimental vaccinia-based pandemic H1N1 influenza live vaccines expressing either the hemaglutinin or the neuraminidase of the novel swine H1N1 influenza strain were analysed.
Gene_expression (expressing) of H1N1 associated with pox virus infection, influenza virus infection and sprains and strains
7) Confidence 0.01 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2922371 Disease Relevance 1.15 Pain Relevance 0
We used two respiratory viruses, RSV (strain A2) and influenza virus A/Puerto Rico/8/34 (H1N1), which were administered IN, and a non-respiratory virus, a recombinant Western Reserve (WR) strain of vaccinia virus (VV) expressing the RSV M2-1 protein (VV-M2), which was administered either by the IN or ID route.
Gene_expression (expressing) of H1N1 in respiratory associated with pox virus infection, influenza virus infection, sprains and strains and respiratory syncytial virus
8) Confidence 0.01 Published 2008 Journal Virol J Section Body Doc Link PMC2561024 Disease Relevance 1.70 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox